Mobile Health Apps Becoming More Popular Among Patients and Clinicians
Mobile health applications have become a permanent fixture in the lives of patients and clinicians.
The main objection among clinical researchers is that commercially developed products often lack a scientific basis for their selection of features.
Sandoz and Pear Therapeutics announced the launch of reSET-O, a new digital therapeutic for patients aged ≥18 years with opioid use disorder (OUD) currently under clinician care.
HeartGuide is designed as a wrist watch that uses the oscillometric cuff method, the standard for medical-grade personal blood pressure measurement.